
AI-enhanced scalable retina screen for newborns - a new standard for babies' vision screening11-50 Employees
- B2C
- Early StageStartup in initial stages
Pr3vent Funding
Pr3vent is active in the following markets / industries: health care, health care information technology, artificial intelligence and baby and kids. The company has secured funding across 1 rounds, totaling in an amount of $2.5M. Their most recent funding was raised on December 31, 2018.
Funding Rounds
S
$2500000Investors of Pr3vent
Emmett Cunningham
Managing Director at Clarus Funds, LLC. Training in Ophthalmology, Neuroscience, Immunology
Rounds
S
Skyview Capital
Rounds
S